US Pharma MarketingMSD wins FDA approval for cholesterol pill to help plug Keytruda void
MSD wins FDA approval for cholesterol pill to help plug Keytruda void is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
MSD has outpaced rivals to market the first PCSK9 inhibitor in pill form for patients with high cholesterol.
Source: Pharmaceutical Technology